biotech chapter 4 Word Scramble
|
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Question | Answer |
purity | the absence of impurity |
sterility | free from microorganims |
pyrogenicity | the ability to cause fever |
use these to increase solubility, so the hydrophobic protein can stay dissolved: | small amount of detergent, salts |
aggregation is going to happen so, how can we make it not stick to other molecules? | Put in another protein: albumin, other proteins, coat surfaces so the recombinant protein will not stick to the surface |
add these excipients for pH | a buffer to neutralize NOT bicarbonate Phosphate buffered saline (PBS), acetate, and citrate are good |
dissolved in oxygen? | sealed vial under nitrogen, antioxidant like ascorbic acid |
Natural antioxidant | glutathione |
how do you make glutathione? | use three peptides: glutamine, cystine, glycine |
which one of the three amino acids in glutathione is the antioxidant | cystine because of the sulfur group |
Preservatives used as excipients | bacteriostatic stuff (inhibit growth but does not kill), mercury compound, phenol, beta hydroxy benzoic acids, alcohol |
hydration excipients are used for what? | to stabilize the protein |
hydration excipients: | polyethylene glycol, other poly alcohol, sugars (dextrose), and salts |
substances or containers to which proteins in solution may adhere to | container that is glass (hydrophobic) plastic, rubber stopper, almost any surface is hydrophobic |
1st step in freeze drying | freeze the solution |
2nd step in freeze drying | primary drying (begin the sublimation) |
primary drying | most of the water comes off now, use low pressure, and maintain temperature, have to slowly add heat to maintain the temperature |
freeze the solution | ice crystals form |
3rd step in freeze drying | secondary drying- that last little water needs to come off |
secondary drying | maintain the pressure, heat up the sample slowly |
some proteins are stored at: | room temperature, refrigerator temperature, or even lower temperatures |
which of the 3 is going to be the fastest: IM, IV, or SC? | IV is the fastest |
why might it be bad if IM and SC hold onto the protein and let it go slowly into the bloodstream? | because the protein could be exposed to proteases and can be degraded if it is just sitting around |
if you do not like needles? | rectal, inhalation, buccal, nasal, vaginal, transdermal patch |
what is a good route of administration for people who are vomiting | rectal |
absorption enhancers | iontophroesis. it disrupts the skin to let the drug across the skin |
iontophroesis | electric current to let the proteins into the skin |
main goal of absorption enhancers | disrupt the skin |
open loop delivery methods: | the open loop is used because the delivery is continuous not responding to changes in data |
what happens if you close the loop? | you take the data you are collecting and utilize/analyze it. then make changes based on that analysis. reassess |
mechanical pumps (Open loop delivery methods) | embed in patients and delivers drug when needed |
osmotically driven systems (open loop) | put is surgically. give a slow steady release. water pumps out the drug |
conjugate a protein into some other molecule (open loop) | join with another molecule like polyethylene glycol. it increases the time that the protein stay at the injection site (slowly released) |
PLGA- polulactic/polyglycolic acid (open loop) | the protein is protected by micro spheres and it stays at the injection site longer |
closed loop systems include | biosensor, algorithm, pump system |
algorithm | calculates the required input rate for delivery |
monospecific antibodies are identical because... | they are produced by one type of immune cell that are all clones of a single parent cell |
immunoconjugates are.. | antibodies conjugated to a second molecule, usually a toxin like ricin |
what are immunoconjugates used for | used in immunotherapy and to develop monoclonal antibody therapy as chemotherapy |
bispecific monoclonal antibody | are manufactured from two separate antibodies to create a molecule with two different binding sites |
colloidal particulate carrier systems: | liposomes, albumin microspheres, biodegradable polycyanoacrylate nanoparticles, polylactic acid microspheres, LDL |
potential advantages of colloidal particulate carrier systems | macrophages encapsulate the drug to protect from degradation. they are similar to the rate-controlled delivery methods because they can persist in the blood for hours to days. |
disadvantages of colloidal particulate carrier systems | they cannot permeate through membranes |
Created by:
ljamison
Popular Science sets